AVACTA GROUP
Avacta Group plc is a provider of technologies, consumables and reagents for the life science markets, from drug discovery to diagnostics. It is engaged in the research, development, production and delivery of instrumentation and services for the biopharmaceutical drug development and clinical diagnostics markets using biophysical technology. The Company has two segments: Analytical and Animal Health. The Analytical segment provides tools and contract services for early stage protein characteris... ation and analysis for biopharmaceutical drug developers. The Animal Health provides tools and contract services to assist diagnosis of conditions in animals to enable faster treatment for veterinarians. The Company’s subsidiaries include Avacta Limited, Avacta Analytical Limited, Oriental Fine Foods Limited, Avacta Health Limited, TheraGenetics Limited and TheraGenetics Inc. ###Readybuy Plc acquires Avacta Ltd in a reverse merger and changed name to Avacta Group Plc in 2004. Readybuy was founded in 2003.###
AVACTA GROUP
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2003-01-01
Address:
Wetherby, York, United Kingdom
Country:
United Kingdom
Website Url:
http://www.avacta.com
Total Employee:
11+
Status:
Active
Contact:
+08444140452
Email Addresses:
[email protected]
Total Funding:
34.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Alkermes
Alkermes is a biotechnology company that develops, manufactures and commercializes medicines for the treatment of chronic diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-01-11 | Aptuscan | Aptuscan acquired by Avacta Group | N/A |
| 2010-01-01 | ReactivLab | ReactivLab acquired by Avacta Group | N/A |
| 2009-03-03 | Curidium Medica | Curidium Medica acquired by Avacta Group | 6.18 M GBP |
| 2009-02-09 | Avacta Animal Health | Avacta Animal Health acquired by Avacta Group | N/A |
| 2009-01-29 | TheraGenetics | TheraGenetics acquired by Avacta Group | 2 M GBP |
| 2007-11-14 | Oxford Medical Diagnostics | Oxford Medical Diagnostics acquired by Avacta Group | N/A |
Investors List
IP Group
IP Group investment in Post-IPO Equity - Avacta Group
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-13 | AffyXell Therapeutics | Avacta Group investment in Corporate Round - AffyXell Therapeutics | N/A |
Official Site Inspections
http://www.avacta.com Semrush global rank: 1.25 M Semrush visits lastest month: 32.83 K
- Host name: 212-71-248-28.ip.linodeusercontent.com
- IP address: 212.71.248.28
- Location: London United Kingdom
- Latitude: 51.5164
- Longitude: -0.093
- Timezone: Europe/London
- Postal: EC2V
